Skip to main content

ADCs Anti-drug conjugates

Articles  —  17 April Apr 2026

Labcorp China BioA Lab passes U.S. FDA unannounced inspection with Zero Observations

Read More about Labcorp China BioA Lab passes U.S. FDA unannounced inspection with Zero Observations
Articles  —  29 September Sep 2025

Navigating complexities in ADC development with specialized global laboratory support and scientific expertise

Read More about Navigating complexities in ADC development with specialized global laboratory support and scientific expertise
Articles  —  14 May May 2024

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese)

Read More about Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese)
Articles  —  8 April Apr 2024

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials

Read More about Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials
Articles  —  6 December Dec 2023

Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay

Read More about Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay
Articles  —  17 October Oct 2022

Exploring metastatic breast cancer immunotherapies: Are ADCs and ICIs the answer?

Read More about Exploring metastatic breast cancer immunotherapies: Are ADCs and ICIs the answer?